Pay in 4 interest-free payments of $7.30 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
In most people, the body produces enough carnitine
Is it worth the money
Use of REPATHA for this indication is supported by evidence from an adequate and well-controlled trial in adults and pediatric patients aged 13 years and older with HoFH (including 7 pediatric patients treated with REPATHA) and from open-label studies which included an additional 19 pediatric patients aged 11 years and older with HoFH not previously treated with REPATHA [see Adverse Reactions (6.1) and Clinical Studies (14)]
Blurred vision and visual impairment were relatively high with both oral and injectable drugs
For the gram-negative bacteria P
US$ 26.62
US$ 28.35
US$ 25.57
